Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: An analysis of the surveillance, epidemiology, and end results database

Cancer

Volumn 117, Issue 17, 2011, Pages 3908-3916

  Shridhar, Ravi ^a   Dombi, George W ^b   Finkelstein, Steven E ^a   Meredith, Kenneth L ^a   Hoffe, Sarah E ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

gastrectomy; gastric cancer; lymph node dissection; preoperative radiation; Surveillance, Epidemiology, and End Results

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; COLLOID CARCINOMA; CONTROLLED STUDY; DEATH; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARTIAL BODY RADIATION; PARTIAL GASTRECTOMY; POSTOPERATIVE RADIOTHERAPY; PREDICTION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH ANTRUM RESECTION; STOMACH CANCER; STOMACH CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TOTAL STOMACH RESECTION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 80051946372     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25995     Document Type: Article

References (19)

1. Hohenberger P, Gretschel S,. Gastric cancer. Lancet. 2003; 362: 305-315. (Pubitemid 36936845)
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108. (Pubitemid 40372904)
3. Macdonald JS,. Gastric cancer-new therapeutic options. N Engl J Med. 2006; 355: 76-77.
4. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001; 345: 725-730.
5. Coburn NG, Govindarajan A, Law CH, et al. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients. Ann Surg Oncol. 2008; 15: 500-507.
6. Hundahl SA, Macdonald JS, Benedetti J, et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002; 9: 278-286. (Pubitemid 34298633)
7. Kelsen DP,. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116. J Clin Oncol. 2000; 18: 32S-34S.
8. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355: 11-20.
9. Zhang ZX, Gu XZ, Yin WB, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)-report on 370 patients. Int J Radiat Oncol Biol Phys. 1998; 42: 929-934.
10. Skoropad V, Berdov B, Zagrebin V,. Concentrated preoperative radiotherapy for resectable gastric cancer: 20-year follow-up of a randomized trial. J Surg Oncol. 2002; 80: 72-78. (Pubitemid 34569172)
11. Fiorica F, Cartei F, Enea M, et al. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev. 2007; 33: 729-740. (Pubitemid 350082668)
12. Skoropad VY, Berdov BA, Mardynski YS, et al. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Eur J Surg Oncol. 2000; 26: 773-779. (Pubitemid 32059836)
13. Shchepotin IB, Evans SR, Chorny V, et al. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol. 1994; 3: 37-44. (Pubitemid 24171939)
14. Coburn NG, Guller U, Baxter NN, et al. Adjuvant therapy for resected gastric cancer-rapid, yet incomplete adoption following results of intergroup 0116 trial. Int J Radiat Oncol Biol Phys. 2008; 70: 1073-1080. (Pubitemid 351296112)
15. Kozak KR, Moody JS,. The survival impact of the intergroup 0116 trial on patients with gastric cancer. Int J Radiat Oncol Biol Phys. 2008; 72: 517-521.
16. Ajani JA, Winter K, Okawara GS, et al. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol. 2006; 24: 3953-3958. (Pubitemid 46630744)
17. Balandraud P, Moutardier V, Giovannini M, et al. Locally advanced adenocarcinomas of the gastric cardia: results of pre-operative chemoradiotherapy. Gastroenterol Clin Biol. 2004; 28: 651-657. (Pubitemid 39318153)
18. Klautke G, Foitzik T, Ludwig K, et al. Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma. Strahlenther Onkol. 2004; 180: 695-700. (Pubitemid 40022276)
19. Rivera F, Galan M, Tabernero J, et al. Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. Int J Radiat Oncol Biol Phys. 2009; 75: 1430-1436.